Cite

HARVARD Citation

    Martinez Sanz, P. et al. (2021). G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment. Journal for immunotherapy of cancer. 9 (5), p. . [Online]. 
  
Back to record